A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
A gene, ATM , that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM , which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3′ kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [49]
Citations
Cites
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
A workbench for multiple alignment construction and analysis
Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 834
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789
Phosphatidylinositol 3-Kinase Encoded by Yeast VPS 34 Gene Essential for Protein Sorting
Schu, P. V., Takegawa, K., Fry, M. J., Stack, J. H., Waterfield, M. D., & Emr, S. D. (1993) · Science · doi:10.1126/science.8385367 · Cited by 778
Research works printed but not linked: 12
- Green, M. H. L., Journal of Cell Science 6: 127 (1987).
- Lange, E., American Journal of Human Genetics 57: 112 (1995).
- Lavin, M. F., Ataxia-Telangiectasia: 235 (1993).
- MCCONVILLE, C.M., GENETIC AND PHYSICAL MAPPING OF THE ATAXIA-TELANGIECTASIA LOCUS ON CHROMOSOME 11Q22-Q23, INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 66: S45 (1994).
- Meyn, M. S., American Journal of Human Genetics 55 Suppl.: A3 (1994).
- OSKATO, R, AMERICAN JOURNAL OF HUMAN GENETICS 53: A1055 (1993).
- Sedgwick, R. P., Handbook of Clinical Neurology 16: 347 (1991).
- Shiloh, Y., American Journal of Human Genetics 55 Suppl.: A49 (1994).
- Shiloh, Y., Ataxia-Telangiectasia: Genetics Neuropathology and Immunology of a Degenerative Disease of Childhood: 111 (1985).
- Shiloh Y. European Journal of Human Genetics in press.
- Uhrhammer, N., American Journal of Human Genetics 57: 103 (1995).
- ZAMPETTIBOSSELE.F, INT J RADIAT BIOL 39: 547 (1981).
Cited by
Items 801–900 of 1,009
The Molecular Pathology of Primary Immunodeficiencies
Lim, M. S., & Elenitoba‐Johnson, K. S. J. (2004) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60493-x · Cited by 70
“The ATM gene is mutated in AT patients from all four complementation groups, indicating that it is probably the sole gene responsible for the disorder.(178) In addition, in AT patients of any age, approximately 10% of all T lymphocytes show the presence of translocations and inversions, mainly involving chromosomes 7…”
BackgroundGreglist: a database listing potential G-quadruplex regulated genes
Zhang, R., Lin, Y., & Zhang, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm787 · Cited by 70
“mutated ENSG00000149311 Ataxia telangiectasia (35) 1 59”
Wang, L., Yang, H., Palmbos, P. L., Ney, G. M., Detzler, T. A., Coleman, D. M., Leflein, J., Davis, M. A., Zhang, M., Tang, W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2289 · Cited by 67
“However, ATDC was later dismissed as an AT gene after the gene responsible for ataxia telangiectasia mutated (ATM) was identified (21).”
Lung disease in ataxia‐telangiectasia
Bott, L., Lebreton, J., Thumerelle, C., Cuvellier, J.-C., Deschildre, A., & Sardet, A. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00338.x · Cited by 69
Sun, J., Zhang, T., Cheng, M., Hong, L., Zhang, C., Xie, M., Sun, P., Fan, R., Wang, Z., Wang, L., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1098-y · Cited by 65
RetractedMerrill, B. J., & Holm, C. (1999) · Genetics · doi:10.1093/genetics/153.2.595 · Cited by 70
Familial pericentric inversion of chromosome 5 in a family with benign neonatal convulsions
Concolino, D., Iembo, M. A., Rossi, E., Giglio, S., Coppola, G., del Giudice, E. M., & Strisciuglio, P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.214 · Cited by 69
Hotti, A., Järvinen, K., Siivola, P., & Hölttä, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203567 · Cited by 69
“The ATM protein has a region homologous to the protein kinase domain of the phosphatidylinositol-3-kinase protein (Savitsky et al., 1995) and possesses kinase activity.”
BackgroundFrom DNA damage to cell cycle arrest and suicide: a budding yeast perspective
Lydall, D. A., & Weinert, T. A. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90003-9 · Cited by 73
Nohmi, T., & Masumura, K. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20110 · Cited by 65
“The gene responsible for AT was cloned and designated ATM (ataxia-telangiectasia-mutated) [Savitsky et al., 1995].”
BackgroundCheng, W.-Y., Wu, S., Hsiang, C., Li, C., Lai, T.-Y., Lo, H., Shen, W.-S., Lee, C.-H., Chen, J., Wu, H.-C., et al. (2008) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x08006235 · Cited by 63
Cesaretti, J. A., Stock, R. G., Atencio, D. P., Peters, S. A., Peters, C. A., Burri, R. J., Stone, N. N., & Rosenstein, B. S. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.02.052 · Cited by 64
Molecular Biology of Chronic Lymphocytic Leukemia
Wierda, W. G. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-412-2_3 · Cited by 66
An ATM homologue from Arabidopsis thaliana: complete genomic organisation and expression analysis
Garcia, V., Salanoubat, M., Choisne, N., & Tissier, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.1692 · Cited by 71
New mutations, polymorphisms, and rare variants in theATM gene detected by a novel SSCP strategy
Castellv�-Bel, S., Sheikhavandi, S., Telatar, M., Tai, L.-Q., Hwang, M., Wang, Z., Yang, Z., Cheng, R., & Gatti, R. A. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:2<156::aid-humu7>3.0.co;2-e · Cited by 63
Self-citationChromatin perturbations during the DNA damage response in higher eukaryotes
Bakkenist, C. J., & Kastan, M. B. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.09.002 · Cited by 69
“Additional mechanistic paradigms within this signaling pathway were rapidly identified as ataxia telangiectasia-mutated (ATM), the gene mutated in ataxia telangiectasia, was found to encode a protein kinase, and p21, a transcriptional target of p53, was determined to be an inhibitor of G1phase cyclin-dependent kinases…”
Induction of genetic instability by gain-of-function p53 cancer mutants
Xu, Y. (2008) · Oncogene · doi:10.1038/sj.onc.1211023 · Cited by 69
“…is a protein kinase mutated in the genetic instability syndrome ataxia-telangiectasia (A-T) characterized by multisystemic defects, including cerebellar degeneration (ataxia), facial telangiectasia, germ cell defects, immunodeficiency, high cancer risk and radiosensitivity (Savitsky et al., 1995).”
BackgroundChoi, S., Gamper, A. M., White, J. S., & Bakkenist, C. J. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13471 · Cited by 67
Steroid‐induced improvement of neurological signs in ataxia‐telangiectasia patients
Broccoletti, T., Giudice, E. D., Amorosi, S., Russo, I., Bonito, M., Imperati, F., Romano, A., & Pignata, C. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02060.x · Cited by 62
“The disease is associated with mutations in the ataxia telangiectasia mutated (ATM) gene encoding for a 370 kDa serine/threonine kinase, that shares sequence similarities with the catalytic subunit of phosphatidyl-inositol-3-kinase [3].”
BackgroundYeo, A. J., Bécherel, O. J., Luff, J., Cullen, J. K., Wongsurawat, T., Jenjaroenpoon, P., Kuznetsov, V. A., McKinnon, P. J., & Lavin, M. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090219 · Cited by 64
“The best characterised of these is ataxiatelangiectasia (A-T) which arises due to mutations in the ATM gene [6].”
BackgroundSelf-citationThe Role of Activation‐Induced Deaminase in Antibody Diversification and Chromosome Translocations
Ramiro, A. R., Reina‐San‐Martin, B., McBride, K. M., Janković, M., Barreto, V. M., Nussenzweig, A., & Nussenzweig, M. C. (2007) · Advances in immunology · doi:10.1016/s0065-2776(06)94003-6 · Cited by 69
Gentile, M., Waltersson, M. A., Schön, F., & Wingren, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204993 · Cited by 70
“In breast cancer, the characterization of the ATM gene (Savitsky et al., 1995a,b) promised to mark the end of the search for candidates, as early studies indicated an increased breast cancer risk in relatives of Ataxia Telangiectasia (AT) patients (Easton, 1994; Swift et al., 1991).”
BackgroundBudzowska, M., Jaspers-Dekker, I., Essers, J., de Waard, H., van Drunen, E., Hanada, K., Beverloo, B., Hendriks, R. W., de Klein, A., Kanaar, R., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600353 · Cited by 62
Heinloth, A. N., Shackelford, R. E., Innes, C. L., Bennett, L., Li, L., Amin, R. P., Sieber, S. O., Flores, K. G., Bushel, P. R., & Paules, R. S. (2003) · Radiation Research · doi:10.1667/rr3047 · Cited by 62
Reduced telomere length in ataxia-telangiectasia fibroblasts
Xia, S. J., Shammas, M. A., & Reis, R. J. S. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(96)00015-8 · Cited by 68
Screening women aged less than 50 years with a family history of breast cancer
Kollias, J., Sibbering, D. M., Blamey, R. W., Holland, P., Obuszko, Z., Wilson, A. R. M., Evans, A. J., Ellis, I. O., & Elston, C. W. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00365-1 · Cited by 62
Identification and characterization of a new gene physically linked to the ATM gene.Preprint
Imai, T., Yamauchi, M., Seki, N., Sugawara, T., Saito, T., Matsuda, Y., Itô, H., Nagase, T., Nomura, N., & Hori, T.-A. (1996) · Genome Research · doi:10.1101/gr.6.5.439 · Cited by 62
Late degeneration of nigro-striatal neurons in ATM−/− mice
Eilam, R., Peter, Y., Groner, Y., & Segal, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00322-1 · Cited by 64
The Cell Cycle and V(D)J Recombination
Desiderio, S. V., Lin, W.-C., & Li, Z. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-50140-1_4 · Cited by 61
Sanal, Ö., Ersoy, F., Yel, L., Tezcan, İ., Metìn, A., Özyürek, H., Gariboglu, S., FIKRIG, S. M., van Berkel, A. I., Rijkers, G. T., et al. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020599810261 · Cited by 61
Infantile onset spinocerebellar ataxia with sensory neuropathy (IOSCA): neuropathological features
Lönnqvist, T. R. I., Paetau, A. E., Nikali, K., von Boguslawski, K., & Pihko, H. S. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00249-4 · Cited by 61
Şanlıoğlu, S., Benson, P. K., & Engelhardt, J. F. (2000) · Virology · doi:10.1006/viro.1999.0137 · Cited by 65
Trans mobilization of genomic DNA as a mechanism for retrotransposon-mediated exon shuffling
Ejima, Y. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg138 · Cited by 61
“3, spans the 146 kb genomic region, and contains 66 exons (21,22).”
Savitsky, K., Uziel, T., Gilad, S., Sartiel, A., Shiloh, Y., Rotman, G., Platzer, M., Rosenthal, A., & Elroy-Stein, O. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.9.1678 · Cited by 61
Self-citationTHE GENETICIST'S APPROACH TO COMPLEX DISEASE
Ghosh, S., & Collins, F. S. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.333 · Cited by 77
Self-citationYoussoufian, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118635 · Cited by 61
Modularity in development and evolution
Schlosser, G., & Thieffry, D. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<1043::aid-bies11>3.0.co;2-c · Cited by 891
Lavin, M. F. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.014 · Cited by 62
Self-citationTomita, M. (2010) · Journal of Radiation Research · doi:10.1269/jrr.10039 · Cited by 67
CRISPR/Cas9 and cancer targets: future possibilities and present challenges
White, M. K., & Khalili, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7104 · Cited by 71
“The ataxia telangiectasia (ATM) tumor suppressor is involved in the cellular response to DNA damage and is mutated in certain kinds of leukemias and lymphomas [85].”
BackgroundSTK38 promotes ATM activation by acting as a reader of histone H4 ufmylation
Qin, B., Yu, J., Nowsheen, S., Zhao, F., Wang, L., & Lou, Z. (2020) · Science Advances · doi:10.1126/sciadv.aax8214 · Cited by 61
Signaling events controlling the molecular response to genotoxic stress
Holbrook, N. J., Liu, Y., & Fornace, A. J. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9088-5_18 · Cited by 67
Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia
Schubert, R., Reichenbach, J., & Zielen, S. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01830.x · Cited by 60
Radiotherapy-induced second cancers: Are we doing enough to protect young patients?
Epstein, R. J., Hanham, I. W. F., & Dale, R. G. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00056-7 · Cited by 60
Restarting the Cell Cycle When the Checkpoint Comes to a Halt
van Vugt, M. A. T. M., Bràs, A., & Medema, R. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1054 · Cited by 72
Bernstein, J. L., Teraoka, S. N., Haile, R. W., Børresen‐Dale, A., Rosenstein, B. S., Gatti, R. A., Diep, A. T., Jansen, L., Atencio, D. P., Olsen, J. H., et al. (2003) · Human Mutation · doi:10.1002/humu.10206 · Cited by 63
“ATM was identified by linkage and positional cloning studies in A-T families [Savitsky et al., 1995; Foroud et al., 1991; Gatti et al., 1988; Lange et al., 1995].”
Self-citationWang, H., Kodavati, M. M., Britz, G. W., & Hegde, M. L. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.784361 · Cited by 63
“The alignment of microhomologous sequences between the broken ends differentiates MMEJ from NHEJ (Sfeir and Symington, 2015).”
BackgroundHydrogen sulfide signalling in neurodegenerative diseases
Tripathi, S. J., Chakraborty, S., Miller, E., Pieper, A. A., & Paul, B. D. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16170 · Cited by 66
“In addition to unsteady gait, this disease manifests as dilation of blood vessels termed telangiectases in the conjunctiva of the eye and facial skin (Savitsky et al., 1995).”
Germ line mutations associated with breast cancer susceptibility
Iau, P. T. C., Macmillan, R. D., & Blamey, R. W. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00378-6 · Cited by 57
“Genetic haplotyping of these AT families localised the AT gene to chromosome 11q23 [131] and it was subsequently cloned by Savitsky and colleagues in 1995 [132], allowing genetic analysis to identify putative AT heterozygotes.”
BackgroundDermatologic manifestations of ataxia-telangiectasia syndrome
Greenberger, S., Berkun, Y., Ben‐Zeev, B., Levi, Y. B., Barziliai, A., & Nissenkorn, A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.12.950 · Cited by 59
“A-T: ataxia-telangiectasia ATM: ataxia-telangiectasia mutated CALM: caf e-au-lait macules A taxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by mutations in the A-T mutated (ATM ) gene.(1) The product of the ATM gene is a serine/threonine protein kinase and a member of the phosphoinositide 3-ki…”
BackgroundPrimary immunodeficiency diseases: dissectors of the immune system
Buckley, R. H. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18517.x · Cited by 60
Leong, T., Whitty, J., Keilar, M., Mifsud, S., Ramsay, J., Birrell, G. W., Venter, D. J., Southey, M. C., & McKay, M. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00728-8 · Cited by 68
TheATMmissense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer
Stredrick, D. L., García‐Closas, M., Pineda, M. A., Bhatti, P., Alexander, B. H., Doody, M. M., Lissowska, J., Pepłońska, B., Brinton, L. A., Chanock, S. J., et al. (2006) · Human Mutation · doi:10.1002/humu.20323 · Cited by 59
“The ATM (ataxia telangiectasia mutated; MIM] 607585) gene, cloned in 1995, is very large and mutations occur throughout its amino acid coding portions [Savitsky et al., 1995].”
BackgroundA late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA
Saviozzi, S., Saluto, A., Taylor, A. M. R., Last, J. I. L., Trebini, F., Paradiso, M. C., Grosso, E., Funaro, A., Ponzio, G., Migone, N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.57 · Cited by 67
Self-citationBonnen, P. E., Story, M. D., Ashorn, C. L., Buchholz, T. A., Weil, M. M., & Nelson, D. L. (2000) · The American Journal of Human Genetics · doi:10.1086/316908 · Cited by 61
“ATM is responsible for the autosomal recessive disease ataxia-telangiectasia (A-T) (Savitsky et al. 1995).”
BackgroundPhosphatidylinositol 3-kinase related kinases
Abraham, R. T. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80132-4 · Cited by 60
von Willebrand, M., Williams, S., Saxena, M., Gilman, J., Tailor, P., Jascur, T. A., Amarante-Mendes, G. P., Green, D. R., & Mustelin, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3994 · Cited by 59
Kishi, S., Wulf, G. M., Nakamura, M., & Lu, K. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204229 · Cited by 64
“…in its human counterpart, the ATM gene, causes ataxia-telangiectasia (AT) both in humans and mice, displaying a wide range of abnormalities, including those related to telomere dysfunction (Barlow et al., 1996; Elson et al., 1996; Savitsky et al., 1995; Xu et al., 1996; Xu and Baltimore, 1996).”
BackgroundMultiple ATM-Dependent Pathways: An Explanation for Pleiotropy
Brown, K. D., Barlow, C., & Wynshaw-Boris, A. J. (1999) · The American Journal of Human Genetics · doi:10.1086/302223 · Cited by 62
DNA damage checkpoints: Implications for cancer therapy
O'Connor, P. M., & Fan, S. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_16 · Cited by 62
Huang, L., Clarkin, K., & Wahl, G. M. (1996) · PubMed · Cited by 66
Role of protein kinase activity in apoptosis
Lavin, M. F., Watters, D. J., & Song, Q. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01920107 · Cited by 64
Self-citationNanoparticle-based radiosensitization strategies for improving radiation therapy
Shen, H., Huang, H., & Jiang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1145551 · Cited by 68
“ATM is a large 370-kDa nuclear phosphoprotein comprising the COOH-terminal domain with about 400 residues and is homologous with the catalytic subunits of phosphatidylinositol 3kinases (Savitsky et al., 1995).”
BackgroundGenetic alterations in hereditary breast cancer
Cipollini, G., Tommasi, S., Paradiso, A., Aretini, P., Bonatti, F., Brunetti, I. M., Bruno, M., Lombardi, G., Schittulli, F., Sensi, E., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh651 · Cited by 57
“Ataxia telangiectasia is an autosomal recessive disorder; it is estimated that 1% of the general population may be heterozygote carriers of the ATM gene [6].”
BackgroundLuciani, M. G., Campregher, C., & Gasché, C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm101 · Cited by 58
RADIATION BIOLOGY: CONCEPTS FOR RADIATION PROTECTION
Preston, R. J. (2004) · Health Physics · doi:10.1097/00004032-200407000-00002 · Cited by 59
“The ATM (Ataxia-Telangiectasia Mutated) gene is mutated in patients with ataxiatelangiectasia (Savitsky et al. 1995).”
BackgroundRadiation, DNA damage and cancer
Hall, J. A., & Angèle, S. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01435-5 · Cited by 66
Gene Expression Phenotype in Heterozygous Carriers of Ataxia Telangiectasia
Watts, J. A., Morley, M. P., Burdick, J. T., Fiori, J. L., Ewens, W. J., Spielman, R. S., & Cheung, V. G. (2002) · The American Journal of Human Genetics · doi:10.1086/342974 · Cited by 57
“Ataxia telangiectasia (AT [MIM 208900]) is an autosomal recessive disease caused by mutations in the gene ataxia telangiectasia mutated (ATM) on human chromosome 11q22-23 (Savitsky et al. 1995).”
BackgroundDamage Control: The Pleiotropy of DNA Repair Genes in Drosophila melanogaster
Sekelsky, J. J., Burtis, K. C., & Hawley, R. S. (1998) · Genetics · doi:10.1093/genetics/148.4.1587 · Cited by 55
Bishop, A. J. R., Hollander, M. C., Kosaras, B., Sidman, R. L., Fornace, A. J., & Schiestl, R. H. (2003) · PubMed · Cited by 66
Hereditary breast cancer: a review
Arver, B. W., Du, Q., Chen, J., Luo, L., & Lindblom, A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0325 · Cited by 70
Kurzbauer, M.-T., Janisiw, M. P., Paulin, L. F., Mota, I. P., Tomanov, K., Krsicka, O., von Haeseler, A., Schubert, V., & Schlögelhofer, P. (2021) · The Plant Cell · doi:10.1093/plcell/koab045 · Cited by 54
“kD (Savitsky et al., 1995; Lavin et al., 2004) and is ordinarily present as a catalytically inactive dimer.”
BackgroundStructure of the human ATM kinase and mechanism of Nbs1 binding
Warren, C., & Pavletich, N. P. (2022) · eLife · doi:10.7554/elife.74218 · Cited by 66
DNA double-strand breaks and ATM activation by transcription-blocking DNA lesions
Sordet, O., Nakamura, A. J., Redon, C. E., & Pommier, Y. (2010) · Cell Cycle · doi:10.4161/cc.9.2.10506 · Cited by 55
“This has been a longstanding concern as the main clinical feature of patients with AT is the acquisition of neuronal degeneration after full (post-replicative) development of the nervous system.(1) Topoisomerase I (TOP1) removes DNA supercoiling generated by transcription by producing transient TOP1 cleavage complexes…”
BackgroundDNA double strand break repair defects, primary immunodeficiency disorders, and ‘radiosensitivity’
Nahas, S., & Gatti, R. A. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328332be17 · Cited by 65
Self-citationInvolvement of p53 in phthalate effects on mouse and rat osteoblasts
Sabbieti, M. G., Agas, D., Santoni, G., Materazzi, S., Menghi, G., & Marchetti, L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22127 · Cited by 57
“Another important protein involved in the response to DNA damage is the ATM protein kinase that interacts with p53 causing phosphorylation at ser 15 [Savitsky et al., 1995; Morgan and Kastan, 1997; Siliciano et al., 1997; Banin et al., 1998].”
BackgroundChang, V. T., Hwang, S. S., Feuerman, M., & Kasimis, B. S. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1175::aid-cncr30>3.0.co;2-n · Cited by 326
ATM missense mutations are frequent inpatients with breast cancer
Sommer, S. S., Jiang, Z., Feng, J., Buzin, C. H., Zheng, J., Longmate, J., Jung, M., Moulds, J., & Dritschilo, A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00119-5 · Cited by 57
The DNA-damage response: new molecular insights and new approaches to cancer therapy
Jackson, S. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370483 · Cited by 71
Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.
Angèle, S., Treilleux, I., Tanière, P., Martel‐Planche, G., Vuillaume, M., Bailly, C., Bremond, A. G., Montesano, R., & Hall, J. A. (2000) · PubMed · Cited by 62
Delia, D., Panigone, S., Tagliabue, E., Fontanella, E., Pierotti, M. A., Mizutani, S., Asada, M., Yamada, T., Taya, Y., Prudente, S., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1168 · Cited by 61
“…tius dwift d), 5 - f a r e to d a - ez 7; AT patients are affected by a wide spectrum of homozygou compound heterozygous germ line mutations of the ATM g primarily deletions or insertions that inactivate the ATM prot (Savitsky et al, 1995a; Gilad et al, 1996; Lakin et al, 1996; Wrigh et al, 1996).”
BackgroundSelf-citationlnterleukin-2 Receptor Signaling Mechanisms
Karnitz, L. M., & Abraham, R. T. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60867-6 · Cited by 59
Premature aging disorders: A clinical and genetic compendium
Schnabel, F., Kornak, U., & Wollnik, B. (2020) · Clinical Genetics · doi:10.1111/cge.13837 · Cited by 61
Dutzmann, C. M., Spix, C., Popp, I., Kaiser, M., Erdmann, F., Erlacher, M., Dörk, T., Schindler, D., Kalb, R., & Kratz, C. P. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01495 · Cited by 57
“Ataxia-telangiectasia (AT; MIM 208900) is an autosomal recessive disorder caused by biallelic pathogenic variants in ATM (ataxia-telangiectasia–mutated), a DNA damage–sensing kinase.(3) Patients present with cerebellar ataxia, conjunctival telangiectasias, oculomotor apraxia, choreoathetosis, immunodeficiency, and an…”
BackgroundBRCA1 Mutation: A Predictive Marker for Radiation Therapy?
Kan, C. E., & Zhang, J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.05.037 · Cited by 60
“For example, the cancer-prone syndrome ataxia telangiectasia is caused by mutation of the ataxia telangiectasia-mutated (ATM) kinase, a central protein to cell cycle checkpoint activation after DSBs (4).”
BackgroundSporadic Alzheimer disease fibroblasts display an oxidative stress phenotype
Ramamoorthy, M., Sýkora, P., Scheibye‐Knudsen, M., Dunn, C., Kasmer, C., Zhang, Y., Becker, K. G., Croteau, D. L., & Bohr, V. A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.018 · Cited by 58
“Furthermore, lack of ATM is associated with high levels of ROS, which in turn activates the ATM-dependent DDR in oxidatively-stressed ATM-proficient cells [60, 61].”
Cristini, A., Park, J.-H., Capranico, G., Legube, G., Favre, G., & Sordet, O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1196 · Cited by 64
“The serine/threonine kinase ATM is critical for DDR (23) and its deficiency leads to the hereditary ataxia telangiectasia (AT) syndrome, which is primarily a neurodegenerative disease (15,24).”
BackgroundDefective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.
Takagi, M., Delia, D., Chessa, L., Iwata, S., Shigeta, T., Kanke, Y., Goi, K., Asada, M., Eguchi, M., Kodama, C., et al. (1998) · PubMed · Cited by 63
Self-citationJohnson, R. T., Gotoh, E., Mullinger, A. M., Ryan, A. J., Shiloh, Y., Ziv, Y., & Squires, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1024 · Cited by 55
Self-citationHarris, C. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03643-1 · Cited by 62
Radiation down-regulates replication origin activity throughout the S phase in mammalian cells
Larner, J. M., Lee, H., Dijkwel, P. A., Little, R. D., Schildkraut, C. L., & Hamlin, J. L. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.3.803 · Cited by 55
Genetic Epidemiology of Breast and Ovarian Cancers
Newman, B. M., Millikan, R. C., & King, M. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017948 · Cited by 55
Alsherbiny, M. A., Bhuyan, D. J., Low, M., Chang, D., & Li, C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810103 · Cited by 61
“ATM gene mutations result in ataxia–telangiectasia, where disrupted recognition and repairs of DNA double-strand breaks (DSBs) take place, with increased risk of cancer [104,105].”
BackgroundKang, B., Guo, R., Tan, X., Zhao, M., Tang, Z.-B., & Lu, Y. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.08.013 · Cited by 57
Cell-cycle signaling: Atm displays its many talents
Westphal, C. H. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00406-4 · Cited by 54
“Ataxia-telangiectasia (AT) is a recessive childhood disease caused by mutations in the ATM (AT-mutated) gene [1].”
Comprehensive scanning of theATM gene with DOVAM-S
Buzin, C. H., Gatti, R. A., Nguyen, V. Q., Wen, C. Y., Mitui, M., Sanal, Ö., Chen, J. S., Nozari, G., Mengos, A. E., Li, X., et al. (2003) · Human Mutation · doi:10.1002/humu.10158 · Cited by 54
“1, contains 66 exons, and produces a 13-kb transcript [Savitsky et al., 1995a; Savitsky et al., 1995b; Platzer et al., 1997].”
BackgroundSelf-citationEXTERNAL RADIATION AND THYROID NEOPLASIA
Sarne, D., & Schneider, A. B. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70318-2 · Cited by 55
Campbell, C. D., Mitui, M., Eng, L., Coutinho, G., Thorstenson, Y. R., & Gatti, R. A. (2002) · Human Mutation · doi:10.1002/humu.10156 · Cited by 54
Self-citationWatanabe, M., Sugai, Y., CONCANNON, P. J., Koenig, M., Schmitt, M., Sato, M., Shizuka, M., Mizushima, K., Ikeda, Y., Tomidokoro, Y., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440220 · Cited by 55
Byrd, P. J. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.11.1785 · Cited by 54
Metadata
- Authors
- Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., & Shiloh, Y.
- Affiliations
- Tel Aviv University (IL)
- Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
- National Institutes of Health (US)
- Sheba Medical Center (IL)
- Yale University (US)
- The University of Texas Southwestern Medical Center (US)
- University of California, Los Angeles (US)
- Sapienza University of Rome (IT)
- Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- QIMR Berghofer Medical Research Institute (AU)
- Erasmus University Rotterdam (NL)
- University of Birmingham (GB)
- University of Sussex (GB)
- ORCID
- Venue
- Science
- Published
- 1995-06-23
- Volume
- 268
- Issue
- 5218
- Pages
- 1749-1753
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159168998
- Cited by
- 2,785
- References
- 54
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 45 · 2023: 34 · 2022: 43 · 2021: 73 · 2020: 60 · 2019: 61 · 2018: 53 · 2017: 67 · 2016: 59 · 2015: 69 · 2014: 80 · 2013: 75 · 2012: 87
- FWCI
- 70.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hg000882-02)
- National Human Genome Research Institute (HG00882)
- National Institute of Neurological Disorders and Stroke (R01NS031763, NS 31763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- ataxia telangiectasia, ATM gene, phosphatidylinositol 3-kinase, positional cloning, complementation groups, cerebellar degeneration, immunodeficiency, chromosomal instability, cancer susceptibility, radiosensitivity, cell cycle regulation, mitogenic signaling, meiotic recombination
- MeSH terms
- Amino Acid Sequence, Ataxia Telangiectasia, Cell Cycle, Chromosome Mapping, Chromosomes, Human, Pair 11, Cloning, Molecular, DNA-Binding Proteins, Female, Genetic Complementation Test, Heterozygote, Humans, Male, Meiosis, Molecular Sequence Data, Neoplasms, Nucleic Acid Hybridization, Proteins, Radiation Tolerance, Signal Transduction, Protein Serine-Threonine Kinases, Sequence Deletion, Phosphotransferases (Alcohol Group Acceptor), DNA, Complementary, Chromosomes, Artificial, Yeast, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.